Sodium acid phosphate with sodium bicarbonate
Sodium acid phosphate with sodium bicarbonate is a phosphate-containing preparation used as an osmotic laxative, including for bowel evacuation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
The phosphate salts act osmotically within the bowel lumen to draw in water, increasing intraluminal volume and stimulating peristalsis to produce evacuation.
Prescribing in practice
- Phosphate preparations can cause significant fluid and electrolyte disturbance, so they should be avoided or used with great caution in renal impairment, cardiac disease and frail elderly patients.
- Ensure adequate hydration, as dehydration and electrolyte shifts are recognised risks.
- Avoid use where there is suspected bowel obstruction or perforation.
Monitoring
Attention to hydration status and, in at-risk patients, electrolyte monitoring is appropriate given the potential for fluid and electrolyte disturbance.
Counselling the patient
- Maintain a good fluid intake while using this preparation.
- Seek advice if you have kidney or heart problems before use.
Evidence & guidelines
Phosphate-based osmotic laxatives are an established option for bowel evacuation, with safety cautions set out in UK prescribing references.
Reference: NICE NG12; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021